Drugs / Antivenom Snakes
re-read 2 minutes ago

Antivenom Snakes

Developed for
snakebite envenomation

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT07500233 Comparator Jan 2027 → Oct 2028 expected snakebite envenomation Liverpool School of Tropical Medicine Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Antivenom Snakes ClinicalTrials.gov intervention name — accepted as the source's own label NCT07500233
Route Intravenous “Standard of care IV antivenom recommended in country” NCT07500233